To further understand the significance of RelA K310 acetylation in GBM in the context of PTEN loss, we generated an endogenous knock-in at the RELA gene by mutating lysine 310 to non-acetylatable arginine (K310R) (Figure 2C), here on referred to as RelA-MUT. The gene discussed is RELA; the disease is glioblastoma.